Nathaniel Roy Landau

12PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsMolecular targetsVirologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 31, 2025
Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models.

Julia Minnee, Wallace Zh Wong, Benjamin S Russell

|Dec 19, 2025
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

Hyuncheol Jung, Pascal Devant, Carter Ching

|Apr 24, 2024
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models.

Takuya Tada, Thomas D Norton, Rebecca Leibowitz

|Jun 29, 2023
Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).

Ramanjit Kaur, Takuya Tada, Nathaniel Roy Landau

|May 30, 2023
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model.

Takuya Tada, Julia Minnee, Nathaniel R Landau

|Jan 30, 2023
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection.

Takuya Tada, Belinda M Dcosta, Julia Minnee

Pageof 2